Copyright Policy

Authors who have published articles in the Journal of Biotechnology and Strategic Health Research (J Biotechnol and Strategic Health Res) accept the following conditions:

Scientific Responsibility

Articles to be published in terms of scientific publishing standards should be prepared in accordance with the criteria of the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME) and the Committee of Publication Ethics (COPE).

It is obligatory for the articles to be convenient in terms of research and publication ethics, the authors are responsible for their articles.

The articles to be sent to start the evaluation process, must be submitted with the Copyright Transfer Form which is signed by all authors.

As the corresponding author, I also warrant that “Association of Experimental, Biotechnological, Clinical and Strategic Health Research and the Journal Editors” will not be held liable against all copyright claims of any third party or in lawsuits that may be filed in the future, and that I will be the only person who will be liable in such cases. I also warrant that the article contains no libellous or unlawful statements, I/we did not use any unlawful method or material during the research, I/we obtained all legal permissions pertaining to the research, and I/we adhered to ethical principles during the research

The author is responsible for the copyright clearance of all elements in the article. In this context, the authenticity of all kinds of content and copyright elements in the article, the copyright problems that the author may have with third parties, and the copyright issues between the author and third parties should be acknowledged and committed to be completely beyond the scope of the journal.

The author states that, under this agreement, Association of Experimental, Biotechnological, Clinical and Strategic Health Research publishes scientific publications in order to contribute to academic publishing; they are not involved in any commercial business or transaction; they are not involved in the content; they must be fully and / or in writing their responsibility for the content.

Ethical Responsibility

Compliance with The Principles of Helsinki Declaration ( must be required in all the studies including “human” factor. In this kind of studies, writers are supposed to state in the methods part that they did the study in compliance with the principles and have taken the “informed consent” of the ethical councils and the other people participating the study.

If “Animal” factor is used in the study, writers are supposed to state in the methods part that they have protected the animal right according to the principles of Guide for the Care and Use of Laboratory Animals ( and they have taken ethics committee approval.

In case reports, patient’s informed consent must be taken regardless of the patient’s identity.

The information of the ethics committee approval should be indicated in the methods part together with the name, date and number of the committee.

Financial Disclosure

If there is a direct/indirect commercial connection or an institution sponsoring in the article, writers must state that they have no commercial relationship with the commercial product, medicine, company etc. and if any, what kind of a relationship they have (consultant, other agreements).

The authors are responsible for reporting all personal and financial relationships that may be involved in the study. Whether there is any conflict of interest in relation to the application or evaluation of the article must be clearly stated.

Author (s)'s Responsibilities

On behalf of all authors, as the corresponding author of the manuscript, I warrant that:

I. The manuscript submitted is my/our own original work;

II. The journal accepts Authorship which defined as ICMJE criterias. “The ICMJE recommends that authorship be based on the following 4 criteria:

a. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work;

b. Drafting the work or revising it critically for important intellectual content;

c. Final approval of the version to be published;

d. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

III. I was authorised by all authors to transfer all royalties related with the manuscript and to enter into a binding contract with the journal as detailed in this Copyright Transfer Form and I will be responsible in the event of all disputes that have occurred and that may occur,

IV. e-mail and contact addresses of all authors have been entered into the Journal of Biotechnology and Strategic Health Research Manuscript Submission page

V. All authors have seen and approved the manuscript as submitted (Journal of Biotechnology and Strategic Health Research receives submissions that are not previously published and/or are not submitted and/or being considered for publication elsewhere). The name, place and the date of the meeting should be written as footnote if manuscripts were presented in any scientific meeting;

VI. The text, illustrations, and any other materials included in the manuscript do not infringe upon any existing copyright or other rights of anyone.

VII. I transfer processing, reproduction, representation, printing, distribution, and online transmittal, to Association of Experimental, Biotechnological, Clinical and Strategic Health Research with no limitation whatsoever,

Author (s)'s Rights

The author(s) doesn’t hold the copyright without restrictions and also doesn’t retain publishing rights without restrictions. Author and general public could not use the work commercially without permission from the publisher.

Additionally, the first publication right belongs to the journal. Exclusive rights (commercial etc.) of the published papers belong to the journal.

There is not a payment to the authors as copyright fee.

Notwithstanding the above, the Contributor(s) or, if applicable the Contributor’s Employer, retain(s) all proprietary rights other than copyright, such as:

a) patent rights;

b) to use, free of charge, all parts of this article for the author’s future works in books, lectures, classroom teaching, or oral presentations;

c) the right to reproduce and disseminate the article for their own purposes provided the copies are not offered for sale.

d) The right of the author (s) to use all or part of the work without paying any fee in the future, in their own books and other academic studies, provided giving reference to the article.

e) The right to include in the open archives of universities or personal websites. Provided that it is specified in the article tag (also by linking the article published in the journal). Author (s) hold intellectual property rights, such as publishing online and / or in social networks (such as personal web pages, course content websites, Researchgate, etc.), are published on the publication of their work.

Please check the license details for more information about reusing the material.

However, reproduction, posting, transmission or other distribution or use of the article or any material contained therein, in any medium as permitted hereunder, requires a citation to the Journal and appropriate credit to Association of Experimental, Biotechnological, Clinical and Strategic Health Research as publisher, suitable in form and content as follows: Title of article, author(s), journal title and volume/issue, Copyright© year. 

  • Dergimiz Uluslararası hakemli bir dergi olup TÜRKİYE ATIF DİZİNİ, TürkMedline, CrossREF, ASOS index, Google Scholar, JournalTOCs, SOBIAD ve ISIindexing dizinlerinde taranmaktadır. TR Dizin(ULAKBİM), SCOPUS, DOAJ için başvurularımızın sonuçlanması beklenmektedir.